The potential for Treg-enhancing therapies in tissue, in particular skeletal muscle, regeneration
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology..
Foxp3+CD4+ regulatory T cells (Tregs) are famous for their role in maintaining immunological tolerance. With their distinct transcriptomes, growth-factor dependencies and T-cell receptor (TCR) repertoires, Tregs in nonlymphoid tissues, termed "tissue-Tregs," also perform a variety of functions to help assure tissue homeostasis. For example, they are important for tissue repair and regeneration after various types of injury, both acute and chronic. They exert this influence by controlling both the inflammatory tenor and the dynamics of the parenchymal progenitor-cell pool in injured tissues, thereby promoting efficient repair and limiting fibrosis. Thus, tissue-Tregs are seemingly attractive targets for immunotherapy in the context of tissue regeneration, offering several advantages over existing therapies. Using skeletal muscle as a model system, we discuss the existing literature on Tregs' role in tissue regeneration in acute and chronic injuries, and various approaches for their therapeutic modulation in such contexts, including exercise as a natural Treg modulator.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:211 |
|---|---|
| Enthalten in: |
Clinical and experimental immunology - 211(2023), 2 vom: 16. März, Seite 138-148 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hanna, Bola S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Exercise |
|---|
| Anmerkungen: |
Date Completed 21.03.2023 Date Revised 17.08.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cei/uxac076 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344915794 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344915794 | ||
| 003 | DE-627 | ||
| 005 | 20231226023852.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cei/uxac076 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1149.xml |
| 035 | |a (DE-627)NLM344915794 | ||
| 035 | |a (NLM)35972909 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hanna, Bola S |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The potential for Treg-enhancing therapies in tissue, in particular skeletal muscle, regeneration |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.03.2023 | ||
| 500 | |a Date Revised 17.08.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. | ||
| 520 | |a Foxp3+CD4+ regulatory T cells (Tregs) are famous for their role in maintaining immunological tolerance. With their distinct transcriptomes, growth-factor dependencies and T-cell receptor (TCR) repertoires, Tregs in nonlymphoid tissues, termed "tissue-Tregs," also perform a variety of functions to help assure tissue homeostasis. For example, they are important for tissue repair and regeneration after various types of injury, both acute and chronic. They exert this influence by controlling both the inflammatory tenor and the dynamics of the parenchymal progenitor-cell pool in injured tissues, thereby promoting efficient repair and limiting fibrosis. Thus, tissue-Tregs are seemingly attractive targets for immunotherapy in the context of tissue regeneration, offering several advantages over existing therapies. Using skeletal muscle as a model system, we discuss the existing literature on Tregs' role in tissue regeneration in acute and chronic injuries, and various approaches for their therapeutic modulation in such contexts, including exercise as a natural Treg modulator | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Tregs | |
| 650 | 4 | |a exercise | |
| 650 | 4 | |a muscular dystrophy | |
| 650 | 4 | |a skeletal muscle | |
| 650 | 4 | |a tissue regeneration | |
| 650 | 4 | |a tissue repair | |
| 700 | 1 | |a Yaghi, Omar K |e verfasserin |4 aut | |
| 700 | 1 | |a Langston, P Kent |e verfasserin |4 aut | |
| 700 | 1 | |a Mathis, Diane |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and experimental immunology |d 1966 |g 211(2023), 2 vom: 16. März, Seite 138-148 |w (DE-627)NLM00001527X |x 1365-2249 |7 nnns |
| 773 | 1 | 8 | |g volume:211 |g year:2023 |g number:2 |g day:16 |g month:03 |g pages:138-148 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cei/uxac076 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 211 |j 2023 |e 2 |b 16 |c 03 |h 138-148 | ||